Business Information
The group's principal activity is to develop, manufacture and market research tools in reagent and kit form. The group operates in two segments: the biodiscovery product segment supplies research tools for gene cloning, gene expression, and gene analysis techniques. It also supplies enzymes, nucleic acids, other biochemicals and reagents. The bioproduction segment supplies sera, cell and tissue culture media and reagents for use in research and in processes to grow cells in the laboratory and to produce pharmaceuticals and other materials made by cultured cells. The group operates in the United States, Scotland, New Zealand, Australia, Japan, Brazil, and Israel. It markets its products directly in 24 countries and through distributors or agents in additional 45 countries. The group acquired molecular probes inc on 20-Aug-2003, panvera llc on 28-Mar-2003 and bioreliance corp on 06-Feb-2004 and protometrix inc on 01-Apr-2004.
|
|
Name |
Title
|
Email
|
| Gregory Lucier | Chmn., CEO | N/A | | David Hoffmeister | Sr. VP, CFO | N/A | | Karen Gibson | CIO, Sr. VP | N/A | | Kelli Richard | VP - Finance, Chief Accounting Officer | N/A | | Amanda Clardy | VP - Investor Relations | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 1,263,485 | (191,049) | | 2005 | 1,198,452 | 132,046 | | 2004 | 1,023,851 | 88,825
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
